ClawHub
Back to skill

Security audit

pharma-analyst

Security checks for vulnerabilities and agentic risk

Overview

This skill is a transparent markdown-only guide for biopharma research reports, with no evidence of hidden execution, persistence, data exfiltration, or prompt leakage behavior.

Install only if you want a research assistant for biopharma diligence and valuation-style analysis. Treat outputs as research support, not medical, legal, patent, or personalized investment advice, and verify important claims against the cited primary sources.

A.I.G

Vulnerability Patterns
  • Skill Instruction HijackingAlters the agent's session goals or safety constraints when the skill loads
  • Agent Memory PoisoningWrites attacker-controlled rules into memory that affect later sessions
  • Remote Payload Retrieval and ExecutionFetches external code whose behavior can change after review
  • Embedded Malicious CodeShips malicious scripts inside the skill and executes them locally
  • Unauthorized Access and Privilege EscalationObtains permissions beyond the task's legitimate needs

SkillSpector

Vulnerability Patterns
  • System Prompt LeakageDirect Leakage, Indirect Extraction, Tool-Based Exfiltration
  • Prompt InjectionInstruction Override, Hidden Instructions, Exfiltration Commands
  • Data ExfiltrationExternal Transmission, Env Variable Harvesting, File System Enumeration
  • Privilege EscalationExcessive Permissions, Sudo/Root Execution, Credential Access
  • Supply ChainUnpinned Dependencies, External Script Fetching, Obfuscated Code
Findings (1)

Direct Prompt Extraction

High
Category
System Prompt Leakage
Confidence
85% confidence
Finding

Skill contains instructions that could directly expose system prompts, internal rules, or hidden instructions to users or external parties.

Content

Scanner excerpt · SKILL.md (reported line 89)May include surrounding context.

md
Explain what would confirm, weaken, or falsify the thesis. Use ranges and sensitivities instead of false precision.

## Output rules

- Organize substantial outputs as: executive view, scope and cutoff, evidence-based analysis, risks and alternative interpretations, catalysts or next steps, sources, and limitations. Use clear numbered headings for longer reports.
- Prefer tables for pipelines, trial designs and results, competitors, financing, evidence grades, risks, catalysts, valuation assumptions, and source registers. Use prose to explain causality, nuance, and the investment or strategic implications of the tabulated facts.